04:07 AM EDT, 08/26/2025 (MT Newswires) -- OS Therapies ( OSTX ) said late Monday it has terminated its equity purchase agreement with Square Gate Capital Master Fund, effective Aug. 26.

Chairman and Chief Executive Paul Romness said its recent warrant exercise inducement and exchange offering provided the company with $4.2 million in gross proceeds to fund operations into mid-2026.

"[O]ur projected monthly burn in the second half of 2025 is significantly less than it was in the first half of 2025," he said.

Shares of the cancer-focused biotech company were up 3.7% in after-market activity.

Price: 2.27, Change: +0.08, Percent Change: +3.65